Funding for this research was provided by:
Technische Universität München
Received: 8 March 2021
Accepted: 22 September 2021
First Online: 11 October 2021
: This project has been supported by financial resources from B. Braun Melsungen AG. Martin Feuerherd reports personal fees, non-financial support, and others from Hönle AG, outside the submitted work. Ann-Kathrin Sippel and Jörg Ingo Baumbach are employees of B. Braun Melsungen AG, which is producing spectrometers for gas analysis. Ulrike Protzer reports grants from Alios, Vir Biotechnology, Roche and Hönle AG; is co-founder and board member of SCG Cell Therapy and board member of the University Hospital Cologne and the University of Regensburg; receives personal fees and others from AbbVie, Arbutus, Dicerna, Gilead Sciences, Leukocare, MSD and Vaccitech, outside the submitted work. Christoph D. Spinner reports grants, personal fees, non-financial support, and others from AbbVie, Aperion, Gilead Sciences, Janssen-Cilag, and GSK/ViiV Healthcare; personal fees from Formycon; grants, personal fees, and others from Eli Lilly; and grants, personal fees, non-financial support, and others from MSD, outside the submitted work. The other authors declare no conflict of interest.